ANIK Anika Therapeutics Inc.

Anika to Participate in Upcoming Virtual Investor Conferences

Anika to Participate in Upcoming Virtual Investor Conferences

BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Michael Levitz, Chief Financial Officer, will participate in the following four virtual investor conferences in September:

  • Barrington Research Fall Investment Conference on Wednesday, September 9, 2020. Dr. Blanchard and Mr. Levitz will participate in virtual one-on-one meetings with investors.
  • Wells Fargo Healthcare Conference on Thursday, September 10, 2020. Dr. Blanchard is scheduled to participate in a fireside chat at 10:40 a.m. ET.
  • Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020. Dr. Blanchard is scheduled to participate in a fireside chat at 8:45 a.m. ET.
  • Sidoti Investor Conference on Thursday, September 24, 2020. Dr. Blanchard is scheduled to present at 9:15 a.m. ET.

Live audio webcasts of the Wells Fargo, Morgan Stanley and Sidoti presentations may be accessed via the section of Anika’s website, . Audio archives of the presentations also will be available on the website.

About Anika Therapeutics, Inc.



(NASDAQ: ANIK), is a global, integrated joint preservation, restoration and regenerative solutions company based in Bedford, Massachusetts. Anika is committed to delivering products along the orthopedic early intervention continuum of care to improve the lives of patients, with a focus on osteoarthritis pain management, sports medicine and joint preservation, restoration and regeneration. The Company has close to three decades of global expertise commercializing innovative products across the orthopedic early intervention continuum of care For more information about Anika, please visit .

For Investor Inquiries:

Anika Therapeutics, Inc.

Kristen Galfetti, 781-457-9000

Executive Director, Investor Relations



For Media Inquiries:

W2O Group

Rachel Girard, 617-379-6760  

 

EN
03/09/2020

Underlying

ANIKAnika Therapeutics Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Anika Therapeutics Inc.

 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BEDFORD, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 2, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $11.45, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired no...

June 5, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on May 1, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 5,000 shares of common stock at a per share exercise price of $14.46, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to two newly hir...

May 12, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika Reports First Quarter 2025 Financial Results

Anika Reports First Quarter 2025 Financial Results First Quarter 2025 Commercial Channel revenue up 18% Integrity™ Implant System continues sequential growth and is on pace to more than double procedures in 2025 Key regulatory and clinical milestones achieved for Hyalofast®, Cingal®, and Integrity Updating Fiscal 2025 OEM Channel revenue guidance and Adjusted EBITDA guidance BEDFORD, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (Nasdaq: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early interventio...

May 9, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika to Participate in the Sidoti Virtual Investor Conference

Anika to Participate in the Sidoti Virtual Investor Conference BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that management will participate in the Sidoti Virtual Investor Conference on Wednesday, May 21, 2025. Anika will host a virtual presentation with Q&A starting at 1:00pm ET. Webcast of the presentation and Q&A will be available in the  section of Anika’s website, . An archive of the presentation will also be a...

May 7, 2025 1 EN
 PRESS RELEASE
Free
ANIK Anika Therapeut...

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, ...

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2025 financial results before the opening of the market on Friday, May 9, 2025, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID numb...

April 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch